×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:
Year Range:

-
Journal
Authors

3740 Total Publications

Corpus Callosum Atrophy Rate in Mild Cognitive Impairment and Prodromal Alzheimer’s Disease
Elahi, S., Bachman, A. H., Lee, S. H., Sidtis, J. J., & Ardekani, B. A.
PMID: 25633676 ; PMCID:4451933 ; 2015; Journal Journal of Alzheimer's Disease; vol. 45; no. 3; pp. 921-31; doi:10.3233/JAD-142631
Exploring Multifractal-Based Features for Mild Alzheimer’s Disease Classification
Ni, H., Zhou, L., Ning, X., & Wang, L.
PMID: 26193379 ; 2015; Journal Magnetics Resonance in Medicine; vol. 76; no. 1; pp. 259-69; doi:10.1002/mrm.25853
A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI
Iglesias, J. E., Augustinack, J. C., Nguyen, K., Player, C. M., Player, A., Wright, M., … Van Leemput, K.
PMID: 25936807 ; PMCID:4461537 ; 2015; Journal Neuroimage; vol. 115; pp. 117-137; doi:10.1016/j.neuroimage.2015.04.042
Optimizing Regions-of-Interest Composites for Capturing Treatment Effects on Brain Amyloid in Clinical Trials.
Tryputsen, V., DiBernardo, A., Samtani, M., Novak, G. P., Narayan, V. A., & Raghavan, N.
PMID: 25114074 ; 2015; Journal Journal of Alzheimer's Disease; vol. 43; no. 3; pp. 809-821; doi:10.3233/JAD-131979
Brain Amyloid-􏰀 Burden Is Associated with Disruption of Intrinsic Functional Connectivity within the Medial Temporal Lobe in Cognitively Normal Elderly
Song Z1, Insel PS2, Buckley S2, Yohannes S3, Mezher A2, Simonson A2, Wilkins S4, Tosun D2, Mueller S2, Kramer JH4, Miller BL4, Weiner MW5.
PMID: 25698758 ; PMCID:4331637 ; 2015; Journal J Neurosci; vol. 35; no. 7; pp. 3240-7; doi:10.1523/JNEUROSCI.2092-14.2015
Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry
J. Pannee, J. Gobom, L. M. Shaw, M. Korecka, E. E. Chambers, M. Lame, R. Jenkins, W. Mylott, M. C. Carrillo, I. Zegers, H. Zetterberg, K. Blennow and E. Portelius
PMID: 26206625 ; 2015; Journal Alzheimers Dement; vol. 12; no. 1; pp. 55-9; doi:10.1016/j.jalz.2015.06.1890
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
Ayton, S., Faux, N. G., & Bush, A. I.
PMID: 25988319 ; PMCID:4479012 ; 2015; Journal Nature Communications; vol. 6; pp. 6760; doi:10.1038/ncomms7760
A potential endophenotype for Alzheimer’s disease: cerebrospinal fluid clusterin
Y. Deming, J. Xia, Y. Cai, J. Lord, P. Holmans, S. Bertelsen, D. Holtzman, J. C. Morris, K. Bales, E. H. Pickering, J. Kauwe, A. Goate, C. Cruchaga and I. Alzheimer's Disease Neuroimaging
PMID: 26545630 ; PMCID:5118651 ; 2015; Journal Neurobiol Aging; vol. 37; pp. 208 e1-208 e9; doi:10.1016/j.neurobiolaging.2015.09.009
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients
Brendel, M., Pogarell, O., Xiong, G., Delker, A., Bartenstein, P., & Rominger, A.
PMID: 25631614 ; PMCID:5849231 ; 2015; Journal European Journal of Nuclear Medicine and Molecular Imaging; vol. 42; no. 5; pp. 716-24; doi:10.1007/s00259-014-2975-4
Alzheimer's disease biomarkers as outcome measures for clinical trials in MCI
Caroli, A., Prestia, A., Wade, S., Kewei, C., Ayutyanont, N., Landau, S., … Initiative, for the A. D. N.
PMID: 25437302 ; PMCID:4437812 ; 2015; Journal Alzheimer's Disease and Associated Disorders; vol. 29; no. 2; pp. 101-109; doi:10.1097/WAD.0000000000000071